You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

apalutamide

Showing 101 - 123 of 123
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial (Pharmacotherapy

Not yet recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Pharmacotherapy Discontinuation
  • +3 more
  • (no location specified)
Feb 11, 2022

Prostate Adenocarcinoma, PSA Level Greater Than Ten, Stage IIB Prostate Cancer AJCC v8 Trial in Houston (Hyperpolarized Carbon C

Active, not recruiting
  • Prostate Adenocarcinoma
  • +9 more
  • Hyperpolarized Carbon C 13 Pyruvate
  • Magnetic Resonance Spectroscopic Imaging
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Progressive Metastatic Castrate-Resistant Prostate Cancer Trial in Worldwide (AZD4635, Durvalumab, Cabazitaxel)

Active, not recruiting
  • Progressive Metastatic Castrate-Resistant Prostate Cancer
  • Sacramento, California
  • +15 more
Mar 22, 2022

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Melbourne (177Lu-PSMA)

Recruiting
  • Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • 177Lu-PSMA
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Mar 28, 2022

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Bellinzona, London Borough of Sutton (Enzalutamide 40mg,

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Enzalutamide 40mg
  • +4 more
  • Bellinzona, Switzerland
  • +1 more
Nov 6, 2023

Metastatic Prostate Cancer Trial in Guangzhou (Metformin)

Not yet recruiting
  • Metastatic Prostate Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Jun 8, 2021

Prostate Cancer, Stage IV Prostate Cancer Trial in Tampa (Luteinizing Hormone Releasing Hormone, New Hormonal Agent, Docetaxel)

Recruiting
  • Prostate Cancer
  • Stage IV Prostate Cancer
  • Luteinizing Hormone Releasing Hormone
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jun 1, 2022

Metastatic Prostate Cancer, Castration-resistant Prostate Cancer Trial in Montréal (Darolutamide (BAY1841788), SBRT)

Recruiting
  • Metastatic Prostate Cancer
  • Castration-resistant Prostate Cancer
  • Darolutamide (BAY1841788)
  • SBRT
  • MontrĂ©al, Quebec, Canada
    Sir Mortimer JGH
Sep 20, 2021

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in United

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +3 more
  • La Jolla, California
  • +21 more
Dec 2, 2022

Solid Tumor Trial in Guangzhou, Tianjin (CBP-1018)

Not yet recruiting
  • Solid Tumor
  • Guangzhou, Guangdong, China
  • +1 more
Jun 15, 2021

Prostate Cancer Trial in United States (ARN-509, LHRH Agonist)

Completed
Has Results
  • Prostate Cancer
  • Scottsdale, Arizona
  • +4 more
Feb 27, 2020

Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Enzalutamide 40 MG, Docetaxel injection)

Not yet recruiting
  • Prostate Cancer
  • Castrate Resistant Prostate Cancer
  • Enzalutamide 40 MG
  • Docetaxel injection
  • (no location specified)
Jan 27, 2023

Metastatic Prostate Cancer, Prostate Adenocarcinoma Trial in Worldwide (Cabozantinib, Atezolizumab, Abiraterone Acetate)

Recruiting
  • Metastatic Prostate Cancer
  • Prostate Adenocarcinoma
  • Tucson, Arizona
  • +259 more
Oct 19, 2022

Castrate-resistant Prostate Cancer (CRPC) Trial in United States (tomivosertib (eFT508))

Completed
  • Castrate-resistant Prostate Cancer (CRPC)
  • tomivosertib (eFT508)
  • New Haven, Connecticut
  • +9 more
Apr 27, 2020

Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • Orange City, Florida
  • +1 more
Nov 23, 2022

Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial in Sydney, Melbourne (Olaparib, 177Lu-PSMA)

Recruiting
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • Sydney, New South Wales, Australia
  • +1 more
Jun 12, 2020

Metastatic Prostate Cancer Men's Attitudes Towards Treatment of

Unknown status
  • Prostate Cancer Metastatic
  • +6 more
  • Semi-Structured Interview Healthcare Professional
  • +3 more
  • Bangor, United Kingdom
  • +14 more
Dec 18, 2020

Prostatic Tumors, Castration-Resistant Trial in Japan (JNJ-56021927)

Completed
  • Prostatic Neoplasms, Castration-Resistant
  • Fukuoka, Japan
  • +3 more
Apr 24, 2020

Metastatic Castration-Resistant Prostate Cancer Trial in United States (ZEN003694, Enzalutamide)

Completed
Has Results
  • Metastatic Castration-Resistant Prostate Cancer
  • Los Angeles, California
  • +7 more
Nov 2, 2021

Metastatic Castrate-resistant Prostate Cancer, Adenocarcinoma, Prostate Trial in United States (TRC253)

Completed
Has Results
  • Metastatic Castrate-resistant Prostate Cancer
  • Adenocarcinoma, Prostate
  • Birmingham, Alabama
  • +4 more
Mar 29, 2021

Prostatic Tumors, Castration-Resistant Trial in New York (JNJ-809, Apalutamide)

Withdrawn
  • Prostatic Neoplasms, Castration-Resistant
  • New York, New York
    (unnamed)
Nov 18, 2016

Healthy Trial in Kumamoto-Shi (JNJ-56021927 60 Milligram, JNJ-56021927 120 Milligram, JNJ-56021927 240 Milligram)

Completed
  • Healthy
  • JNJ-56021927 60 Milligram
  • +2 more
  • Kumamoto-Shi, Japan
    (unnamed)
Jan 10, 2017